BOC Sciences Blog

Ursodeoxycholic acid exacerbates peginterferon-induced interstitial pneumonia in a patient with hepatitis C

Ursodeoxycholic acid exacerbates peginterferon-induced interstitial pneumonia in a patient with hepatitis C

Eradication of hepatitis C virus (HCV) infection is extremely important to either cure hepatitis or prevent the progression of hepatic fibrosis and the development of hepatocellular carcinoma. Antiviral therapy using peginterferon and […]

Production of Canolol from Canola Meal Phenolics via Hydrolysis and Microwave-Induced Decarboxylation

Production of Canolol from Canola Meal Phenolics via Hydrolysis and Microwave-Induced Decarboxylation

Free radicals induce oxidative damage in vivo causing aging and various diseases. They are also the major cause for deterioration, quality loss, and shelf life reduction in oils/fats and fat-containing systems. There are […]

Renal Cell Cancer

Renal Cell Cancer

Renal cell cancer (RCC) is responsible for 3.7 % of all cancers diagnosed yearly and is ranked as the third most common urological cancer in the US population. The average age at diagnosis […]

Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a leading cause of death among cancer patients. The 5-year overall survival rate in patients with localized cancer is 55.2 %, and this decreases to 4.3 % […]

Recent Updates on the Development of Ganetespib as a Hsp90 Inhibitor

Recent Updates on the Development of Ganetespib as a Hsp90 Inhibitor

Heat shock protein 90 (Hsp90) is a highly conserved molecular chaperone which modulates cellular homeostasis and environmental stress responses by interacting with more than 200 proteins, also known as Hsp90 client proteins, […]

Immune Checkpoint Inhibitors in Older Adults

Immune Checkpoint Inhibitors in Older Adults

Cancer is primarily a disease of the older adult with more than 50 % of new cases occurring in adults older than 65 years. The care of older adults with cancer can […]

Immune checkpoint inhibitors: a new frontier in bladder cancer

Immune checkpoint inhibitors: a new frontier in bladder cancer

  Immunotherapy and immune checkpoint inhibition in particular present an exciting opportunity for the treatment of bladder cancer. Over the last 30 years, bladder cancer patients have seen few advances in the […]

Checkpoint inhibitors in immunotherapy of ovarian cancer

Checkpoint inhibitors in immunotherapy of ovarian cancer

Ovarian cancer is a cancerous growth arising from numerous parts, mainly the outer lining of the ovary called germinal epithelium. It is the fifth leading cause of cancer-related death among women, which causes […]

Immune checkpoint inhibitors: a patent review(2010-2015)

Immune checkpoint inhibitors: a patent review(2010-2015)

The ability of the immune system to detect and eliminate cancer was first proposed over 100 years ago. Since then, T cells reactive against tumor-associated antigens have been detected in […]

New Drugs for the Treatment of Myelofibrosis

New Drugs for the Treatment of Myelofibrosis

Myelofibrosis (MF) includes primary MF and MF that has arisen from an antecedent polycythemia vera (PV) or essential thrombocythemia (ET) (post-PV/ET MF). MF can affect patients in various ways, including progressive splenomegaly, cytopenias (particularly […]